Biocon Biologics And Civica Team Up To Boost U.S. Supply Of Affordable Insulin
Biocon Biologics Ltd. and pharmaceutical nonprofit Civica, Inc. are expanding their partnership to bring a new private-label version of Insulin Glargine to the U.S. market, aiming to improve access to affordable insulin for millions of Americans living with diabetes. Under the new multi-year agreement, Biocon Biologics will manufacture and supply Read More










